Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-10-26

Clinical Trial Update: Iloprost Power 15 in Pulmonary Arterial Hypertension [Phase 3]

View source ↗

Summary

Phase 3 clinical trial of Iloprost Power 15 for pulmonary arterial hypertension has completed, with results posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Iloprost Power 15 (iloprost)

Snippet

Sponsor: Actelion | Conditions: Pulmonary Arterial Hypertension | Phase 3 | Status: COMPLETED | Results posted: 2012-10-26